Americold Realty Trust, Inc. Sets Date for Second Quarter 2023 Earnings Release and Conference Call

In this article:
Americold Realty TrustAmericold Realty Trust
Americold Realty Trust

ATLANTA, GA., July 05, 2023 (GLOBE NEWSWIRE) -- Americold Realty Trust, Inc. (NYSE: COLD) (the “Company”), a global leader in temperature-controlled logistics real estate and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced that the Company will release second quarter 2023 financial results after the market closes on Thursday, August 3, 2023. A conference call will be held on Thursday, August 3, 2023 at 5:00 p.m. Eastern Time.

Webcast:
A webcast of the conference call will be available on the Investor Relations section of the Company’s website at www.americold.com. To listen to the live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register and install any necessary audio software.

To Participate in the Telephone Conference Call:
Dial in at least 5 minutes prior to start time:
Domestic: 1-877-407-3982
International: 1-201-493-6780

Conference Call Playback:
Domestic: 1-844-512-2921
International: 1-412-317-6671
Pass code: 13737834
The playback can be accessed through August 17, 2023.

About Americold Realty Trust, Inc.

Americold is a global leader in temperature-controlled logistics real estate and value-added services. Focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, Americold owns and/or operates 243 temperature-controlled warehouses, with approximately 1.5 billion refrigerated cubic feet of storage in North America, Europe, Asia-Pacific, and South America. Americold’s facilities are an integral component of the supply chain connecting food producers, processors, distributors and retailers to consumers.

Contacts:

Americold Realty Trust, Inc.
Investor Relations
Telephone: 678-459-1959
Email: investor.relations@americold.com


Advertisement